HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug gets a second look for kidney patients
Disease control Recruiting nowThis study tests whether a heart failure drug called eplerenone is safe and helpful for people who also have severe chronic kidney disease. Previous studies excluded these patients due to safety concerns, but newer treatments may lower the risks. The trial will enroll 40 particip…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
Genetic clues may explain why exercise helps some heart patients more than others
Knowledge-focused Recruiting nowThis study looks at why some people with heart failure get more benefit from exercise rehab than others. Researchers will measure oxygen use and tiny genetic molecules (microRNAs) in 62 patients before and after a rehab program. The goal is to find markers that predict who will i…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Centre Hospitalier de Corbie • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC